Performance

Most Sites Tell You They're Fast. We Show You.

Live operational performance across the Stryde network. No NDA, no sales call, no cherry-picking. The same numbers our own leadership reviews every Monday.

6.5 wks

Faster startup

Median study startup

Stryde

6.5 wks

University sites

~10 wks

Cancer centers

~24 wks

Site selection to first patient screened, trailing 12 months. Comparators: median activation for industry-sponsored trials at a university site and median across academic cancer centers. Depending on sponsor needs and document readiness, we can activate a site in as little as two weeks.

82 %

Enrollment health

Studies at or ahead of enrollment plan

Stryde

82%

Industry

~50%

Share of currently enrolling studies meeting or beating the sponsor’s enrollment plan. Industry context: many sites under-enroll, and a meaningful share never enroll a single subject, leaving roughly half at or above target.

31 hrs

Rapid response

Median feasibility response time

Stryde

31 hrs

Business hours from request received to preliminary feasibility delivered, trailing 90 days. No published industry benchmark exists for feasibility turnaround, so we publish ours, backed by our 48-hour guarantee.

94 /100

Quality signal

Composite quality score

Windows

96.2%

Query rate

2.1%

Network average across visit-window adherence, data-query rate, safety-reporting timeliness, and regulatory-document currency.

41 %

Representative access

Diverse participant enrollment

Stryde

41%

Industry

~25%

Participants from racial and ethnic minority groups, network aggregate, trailing 12 months. Industry context is approximately one quarter of global trial participants. Drawn from 1.5M+ patients across 100+ specialty clinics.

Our Method

How These Numbers Are Made

Every metric is computed from our clinical trial management system and published as a weekly snapshot after review by our Quality lead. Nothing is hand-typed into this page.

You will never see sponsor names, study identifiers, or per-study data here. Every figure aggregates a minimum of three studies because our confidentiality obligations to sponsors matter as much as our transparency to you.

If a metric would expose a single study, we suppress it for that period and say so.

External Context

Benchmark Sources

The external benchmarks below provide context for how site activation, enrollment and representation perform across the wider clinical research industry.

01 Activating Clinical Trials University of South Florida — median 69 days for industry-sponsored trial activation. 02 AACI Benchmarking Survey JCO Oncology Practice — median activation of 167 days across 61 cancer centers. 03 The State Of Clinical Trial Activation At Sites Advarra — 80% of investigative sites report activation within 60 days.

04 Tufts Center For The Study Of Drug Development As reported in Applied Clinical Trials — 37% of sites under-enroll and 11% enroll zero subjects.

05 Applied Clinical Trials Approximately 80% of trials miss initial enrollment targets and timelines, while roughly 25% of global trial participants are people of color.

Current Performance Data

Want This Quarter’s Actual Numbers Today?

Until the live board ships, sponsors can request current metrics by email and receive them the same day, human-sent.

Request Current Metrics